|
|
|
|
| |
|
|
| Grivicich,I.; Mans,D.R.A.; Peters,G.J.; Schwartsmann,G.. |
| Colorectal cancer is one of the most frequent malignancies in humans and an important cause of cancer death. Metastatic colorectal cancer remains incurable with available systemic therapeutic options. The most active cytotoxic drug against this malignancy, the antimetabolite 5-fluorouracil, was developed more than forty years ago, and as a single agent produces responses in only 10 to 15% of patients which in general last less than one year. Efforts to ameliorate these poor results resulted in the 5-fluorouracil/leucovorin combination, which enhances response rates about two-fold, without, however, significantly improving survival rates. The recent emergence of a handful of new 5-fluorouracil analogues and folate antagonists, as well as the topoisomerase I... |
| Tipo: Info:eu-repo/semantics/article |
Palavras-chave: Colorectal carcinoma; 5-fluorouracil; Irinotecan; Oxaliplatin. |
| Ano: 2001 |
URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2001000900001 |
| |
|
|
|
